Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

VTRS

+ Watchlist+ Portfolio

Viatris Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$20.28
52-Week Range
$10.15 – $21.20
Market Cap
$22.79B
P/E (TTM)
—
EPS (TTM)
-0.53
Dividend Yield
2.37%
Advanced Metrics
Price/Book
1.67
PEG Ratio
3.69
Return on Equity
-4.21%
Return on Assets
2.91%
Gross Margin
41.13%
Operating Margin
11.49%
Profit Margin
-4.13%
Current Ratio
1.55
Debt/Equity
0.99
Total Debt
$13.58B
Free Cash Flow
$3.16B
Revenue Growth
-0.30%
Earnings Growth
—
Enterprise Value
$34.82B

Market Snapshot

About

Viatris is a global healthcare company formed through the merger of Mylan and Upjohn, a division of Pfizer. The company focuses on developing, manufacturing, and distributing generic and branded pharmaceutical products across a wide range of therapeutic categories. Viatris serves patients in more than 165 countries with a mission to expand access to quality medicines worldwide.